First-line paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus

被引：0
|
作者：
Zhang, X. [1 ]
Shen, L. [1 ]
Li, J. [1 ]
Li, Y. [1 ]
Li, J. [1 ]
Jin, M. L. [1 ]
机构：
[1] Beijing Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15157
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus
    Zhang, Xiaodong
    Shen, Lin
    Li, Jie
    Li, Yan
    Li, Jian
    Jin, Maolin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 29 - 33
  • [2] Paclitaxel and cisplatin in patients with advanced squamous cell carcinoma of the esophagus.
    Gong, J.
    Zhang, X.
    Shen, L.
    Li, J.
    Li, Y.
    Li, J.
    Zhang, X.
    Zhou, J.
    Dong, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] HEALTH OUTCOME IN PATIENTS WITH ADVANCED OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA TREATED WITH FIRST-LINE SINTILIMAB PLUS CISPLATIN AND PACLITAXEL VERSUS CISPLATIN AND PACLITAXEL
    Sun, L.
    VALUE IN HEALTH, 2022, 25 (12) : S53 - S53
  • [4] Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    Rose, PG
    Blessing, JA
    Gershenson, DM
    McGehee, R
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2676 - 2680
  • [5] Phase II trial of irinotecan and cisplatin combination as first-line chemotherapy in patients with advanced esophageal squamous-cell carcinoma: An interim report
    Zhang, X.
    Shen, L.
    Li, J.
    Li, Y.
    Zhou, J.
    Lu, Z.
    Lu, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [6] Phase II trial of paclitaxel and cisplatin combination given biweekly as first-line chemotherapy in patients with advanced or metastatic squamous cell carcinoma of esophagus from a single center in China.
    Zhou, Y.
    Huang, J.
    Yang, L.
    Cai, G. R.
    Xu, H. B.
    Wang, W. J.
    Shi, K. Y.
    Sun, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma
    Munhoz, Rodrigo R.
    Nader-Marta, Guilherme
    de Camargo, Veridiana P.
    Queiroz, Marcello M.
    Cury-Martins, Jade
    Ricci, Herminia
    de Mattos, Marcela R.
    de Menezes, Thiago A. F.
    Machado, Guilherme U. C.
    Bertolli, Eduardo
    Barros, Milton
    de Souza, Carina E.
    Franke, Fabio
    Ferreira, Fabio O.
    Feher, Olavo
    de Castro Jr, Gilberto
    CANCER, 2022, 128 (24) : 4223 - 4231
  • [8] Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus
    Johnsson, A
    Hoglund, P
    Grubb, A
    CavallinStahl, E
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 39 (1-2) : 25 - 33
  • [9] Cost-Effectiveness Analysis of Toripalimab Plus Paclitaxel and Cisplatin as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
    Fang, Rui
    Wang, Suiqiong
    Liu, Yongqian
    Xu, Jun
    ADVANCES IN THERAPY, 2023, 40 (03) : 1019 - 1030
  • [10] Cost-Effectiveness Analysis of Toripalimab Plus Paclitaxel and Cisplatin as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
    Rui Fang
    Suiqiong Wang
    Yongqian Liu
    Jun Xu
    Advances in Therapy, 2023, 40 : 1019 - 1030
12345